VSee Health, Inc. Operating Cash Flow
VSee Health, Inc. (VSEE) reported Operating Cash Flow of -$3.63 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- VSee Health, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$1.17M.
- VSee Health, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$2.45M.
- VSee Health, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.93M.
- VSee Health, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$754.54K.
- VSee Health, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$3.45M.
- VSee Health, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$5.79M.
- VSee Health, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$632.60K.
- VSee Health, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$1.39M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 7 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$3.63M 10-Q · filed 2026-08-14 | -$5.55M derived: sum of 3 quarters · filed 2026-08-14 | -$6.31M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2026-03-31 | -$2.45M 10-Q · filed 2026-05-15 | -$4.38M derived: sum of 2 quarters · filed 2026-05-15 | -$5.13M derived: sum of 3 quarters · filed 2026-05-15 | -$5.46M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-12-31 | -$1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$2.68M derived: sum of 2 quarters · filed 2026-03-31 | -$3.01M derived: sum of 3 quarters · filed 2026-08-14 | -$3.45M 10-K · filed 2026-03-31 | |||||
| 2025-09-30 | -$754.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$1.08M derived: sum of 2 quarters · filed 2026-08-14 | -$1.52M 10-Q · filed 2025-11-14 | -$4.49M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-06-30 | -$324.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$765.09K 10-Q · filed 2026-08-14 | -$3.74M derived: sum of 3 quarters · filed 2026-08-14 | -$3.96M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-03-31 | -$440.49K 10-Q · filed 2026-05-15 | -$3.41M derived: sum of 2 quarters · filed 2026-05-15 | -$3.64M derived: sum of 3 quarters · filed 2026-05-15 | -$6.81M derived: sum of 4 quarters · filed 2026-05-15 | |||||
| 2024-12-31 | -$2.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$3.20M derived: sum of 2 quarters · filed 2026-03-31 | -$6.37M derived: sum of 3 quarters · filed 2026-03-31 | -$5.79M 10-K · filed 2026-03-31 | |||||
| 2024-09-30 | -$221.03K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-11-14 | -$3.39M derived: sum of 2 quarters · filed 2025-11-20 | -$2.82M 10-Q · filed 2025-11-14 | -$2.92M derived: sum of 4 quarters · filed 2025-11-20 | |||||
| 2024-06-30 | -$3.17M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2025-11-20 | -$2.59M 10-Q/A · filed 2025-11-20 | -$2.70M derived: sum of 3 quarters · filed 2025-11-20 | -$2.75M derived: sum of 4 quarters · filed 2025-11-20 | |||||
| 2024-03-31 | $579.29K 10-Q · filed 2025-10-15 | -$335.32K 10-Q · filed 2024-05-15 | $470.13K derived: sum of 2 quarters · filed 2025-10-15 | $421.33K derived: sum of 3 quarters · filed 2025-10-15 | $287.36K derived: sum of 4 quarters · filed 2025-10-15 | ||||
| 2023-12-31 | -$109.16K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-29 | -$157.95K derived: sum of 2 quarters · filed 2025-08-29 | -$291.93K derived: sum of 3 quarters · filed 2025-08-29 | -$632.60K 10-K/A · filed 2025-08-29 | -$962.04K 10-K · filed 2024-04-12 | ||||
| 2023-09-30 | -$48.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$182.77K derived: sum of 2 quarters · filed 2024-11-14 | -$523.44K 10-Q · filed 2024-11-14 | -$640.58K 10-Q · filed 2023-11-20 | -$1.20M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$133.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-09-23 | -$474.64K 10-Q · filed 2024-09-23 | -$590.72K 10-Q · filed 2023-08-21 | -$1.15M derived: sum of 3 quarters · filed 2024-09-23 | -$1.30M derived: sum of 4 quarters · filed 2024-09-23 | ||||
| 2023-03-31 | -$340.67K 10-Q · filed 2024-05-15 | -$1.02M derived: sum of 2 quarters · filed 2024-05-15 | -$1.16M derived: sum of 3 quarters · filed 2024-05-15 | -$1.48M derived: sum of 4 quarters · filed 2024-05-15 | |||||
| 2022-12-31 | -$676.17K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-12 | -$822.33K derived: sum of 2 quarters · filed 2024-04-12 | -$1.14M derived: sum of 3 quarters · filed 2024-04-12 | -$1.39M 10-K · filed 2024-04-12 | |||||
| 2022-09-30 | -$146.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | -$464.75K derived: sum of 2 quarters · filed 2023-11-20 | -$715.04K 10-Q · filed 2023-11-20 | ||||||
| 2022-06-30 | -$318.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | -$568.89K 10-Q · filed 2023-08-21 | |||||||
| 2022-03-31 | -$250.29K 10-Q · filed 2023-05-15 | ||||||||
| 2021-12-31 | -$600.11K 10-K · filed 2023-04-12 | ||||||||
| 2021-09-30 | -$180.00 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |